Article info

Download PDFPDF

Human epidermal growth factor receptor-2 (HER2) is a potential therapeutic target in extramammary Paget’s disease of the vulva
Free

Authors

  1. Correspondence to Dr Michele Bartoletti, Department of Clinical Oncology and Prevention, Centro di Riferimento Oncologico, Aviano 33081, Italy; michele.bartoletti{at}cro.it
View Full Text

Citation

Bartoletti M, Mazzeo R, De Scordilli M, et al
Human epidermal growth factor receptor-2 (HER2) is a potential therapeutic target in extramammary Paget’s disease of the vulva

Publication history

  • Received June 19, 2020
  • Revision received September 1, 2020
  • Accepted September 3, 2020
  • First published September 30, 2020.
Online issue publication 
November 02, 2020

Article Versions

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.